NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Intel
INTC
US Stock MarketDetailed Quotes
LYRA Lyra Therapeutics
- 0.194
- -0.020-9.16%
Close Mar 3 16:00 ET
12.72MMarket Cap-0.13P/E (TTM)
0.215High0.194Low727.18KVolume0.215Open0.214Pre Close147.04KTurnover1.57%Turnover RatioLossP/E (Static)65.46MShares6.79052wk High0.62P/B9.04MFloat Cap0.16352wk Low--Dividend TTM46.48MShs Float22.000Historical High--Div YieldTTM9.39%Amplitude0.163Historical Low0.202Avg Price1Lot Size
About Lyra Therapeutics Company
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Company Profile
SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Company Executives
- Name
- Position
- Salary
- Dr. Maria Palasis, PhD
- Director, President and Chief Executive Officer
- 1.79M
- Dr. Richard Nieman
- Chief Medical Officer
- --
- Jason Cavalier
- Chief Financial Officer, Treasurer and Principal Accounting Officer
- --
- Dr. Harlan W. Waksal,M.D.
- Executive Chairman of the Board
- 625.06K
- C. Ann Merrifield
- Independent Director
- 113.06K
- W. Bradford Smith
- Independent Director
- 123.81K
- James R. Tobin
- Lead Independent Director
- 152.31K
- Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
- Independent Director
- 109.06K